諸外国における妊娠・出産等に関する情報提供事例収集 2
|
|
|
- しげのぶ さんきち
- 5 years ago
- Views:
Transcription
1 樽 1. WHO 2012World Health Statistics Centers for Disease Control and Prevention; CDC , , ,2000,2009CDC/NCHS 36, National Vital Statistics System and National Survey of Family Growth: CDC, Abortion Surveillance System; and Guttmacher Institute
2 , CDC/NCHS 39, National Vital Statistics System and National Survey of Family Growth: CDC, Abortion Surveillance System; and Guttmacher Institute
3 CDC/NCHS, National Survey of Family Growth, CDC/NCHS, National Survey of Family Growth, Society for Assisted Reproductive Technology SART
4 Fertility Clinic Success Rate and Certification Act FCSRCA, or Public Law Centers for Disease Control and Prevention; CDC National ART Surveillance System NASSAmerican Society for Reproductive Medicine; ASRMSART CDC RESOLVE American Fertility Association, Fertile Hope Assisted Reproductive Technology: ART 2002National Survey of Family Growth NSFG % % 41, % % , CDC 30
5 647.7% ART Assisted Reproductive Technology: ART ,260ART47,09061, % ART ART 46.4 % Patient Protection and Affordable Care Act ACA ACA 3. National Public Health Action Plan for the Detection, Prevention and Management of Infertility 22002National Survey of Family Growth NSFG % 41, CDC 1.ART
6 2010 CDCNational Public Health Action Plan for the Detection, Prevention and Management of Infertility 47 CDC Fertility IQ 2011 Fertility IQ 2011EMD
7 , Fertility IQ Fertility IQ
8 19.0% 6.0% 43.0% 8.0% 18.0% 3.0% 7.0% 32.0% 64.0% Fertility IQ
9 Fertility IQ % 78%89-96% 35
10 Fertility IQ NPO 36
11 5-1. CDC ART CDC ART CDC20 ART 6 ARTART ART ART a.b.artc. d.art4 NPO 37
12 Reproductivefacts.org Reproductivefacts.org21 FAQ 5-3. Society for Assisted Reproductive Technology SART 52 SART ARTFAQ Reproductivefacts.org 38
13 5-4. RESOLVE: The National Infertility Association RESOLVE: The National Infertility Association RESOLVE NPO Fertility Hope LiveStrongNPOFertility Hope 蔽 ART 蔽 39
14 ART 5-6. Maria talks 55 Maria talkshiv/aids 1983 NPO 1980 HIV/AIDS DV Roe v. Wade, 410 U.S
15 NPO CDC GIFT ICSI ZIFT 2005 MassHealth MassHealth , ACA
16 Who s in the family? Who s in the family? , ,
17 43
18 The Your Fertility 59 the Fertility Coalition Louise Johnson
19 ( ) 4 ( ) /4 45 1/ ( ) ,000 5 (Robert Norman)
20 DVD ( ) DVD Fertility Week ( )
諸外国における妊娠・出産等に関する情報提供事例収集 1
... 1... 3 1.... 3 2.... 3 3.... 4... 5 1... 5 2... 5 3... 6 4... 6 5... 6 6... 7... 8 1.... 8 2. Fertility Awareness... 8 3.... 9 4.... 11 1 Fertility Status Awareness Tool FertiSTAT...12...13 1. Fertility
フィナレビ106号.indb
2009 3 30 2009 4 14 CDC 2009 4 25 WHO 2009 4 26 2009 4 28 2009 4 28 2009 4 30 2009 5 1 2009 5 8 6 2009 5 9 2009 5 23 2009 6 3 2009 6 9 2500 2009 6 12 WHO 6 2009 6 28 2009 8 9 1 1 2009 8 15 2009 8 19 2010
第3章.doc
70 3 71 Freedman, Ronald (1975),The Sociology of Human Fertility 72 Bongaarts Bongaarts1978 73 Infecundity Surgically sterile Impaired fecundity Contraceptively sterile Noncontraceptively sterile Nonsurgically
1 2 3 4 5 6
1 2 3 4 5 6 1 2 12% 21% 2% 22% 2% 23% 6% 5% 13% 76% 1,2 1, 8 6 4 2 8 822 851 935 152 16 176 2 1,84 257 '2/3 '3/3 '4/3 '5/3 '6/3 9 8 7 6 5 4 3 2 1 75 73 9.4 5.4 8.8 53 6.2 64 4.2 4. 4.5 79 6.9 7.3 3.7
The Heart Healthy Tocotrienol Complex Tocomin SupraBio
The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio 1. Fact Sheet No. 317; World Health Organization (WHO), 2007 2. LLOYD-JONES D. et al. Circulation
21 22 4 5 23 3 11 24 4 23 FAQ 2
21 22 4 5 23 3 11 24 4 23 FAQ 2 3 4 A 15 5 8 19 13 19 5 6 14 5 16 5 9 20 22 18 B 29 30 5 17 47 51 26 18 21 22 27 5 3 48 103 11 3 10 C 7 22 44 103 107 117 127 7 18 5 7 8 5 1 2011 5 24 2 6 22 3 7 27 4 9
untitled
13,000 1 35,400 8,000 1 35,400 2 ~6 46,000 2 ~6 46,000 7 55,000 7 55,200 2,750 2,750 4,910 4,910 149,000 149,000 45,000 75,000 45,000 75,000 189,000 165,400 151,200 132,300 33 29 4 33 29 4 150,410 128,100
C o n t e n t s
2002 C o n t e n t s 3 4 6 7 8 9 10 12 14 16 16 17 18 20 22 23 24 28 30 31 32 36 37 39 40 41 42 43 2002 3 4 2002 2002 5 6 2002 1. 2. 3. 4. 5. 2002 7 1. 2. 3. 4. 1. 2. 3. 4. 8 2002 1. 2. 3. 1. 2. 3. 2002
CSR報告書
2 3 4 6 7 8 9 10 11 12 13 14 18 19 20 22 23 24 25 26 27 2 3 4 5 6 Compliance 7 Internal Control & Information Security A Act P Plan C Check D Do 8 18 4 1 20 4 1 Management System 9 Management System 10
(Travel Medicine) (Emerging Re-emerging Diseases) ) ) ) ) ) ) ) 10 ) 12 ) ) 12 ) 13 ) 14 ) 15 ) 17 ) 18 ) 20 ) 22 24
1999.No2(22) (Travel Medicine) (Emerging Re-emerging Diseases) ) ) ) ) ) ) ) 10 ) 12 ) ) 12 ) 13 ) 14 ) 15 ) 17 ) 18 ) 20 ) 22 24 Travel Medicine Travel Clinic i) ii) iii) ) 200 Emerging Re-emerging Diseases
3228.pwd
1 2 1 P 2 P 1 3 4 5-1- 6 7 8 35 30 25 20 15 10 5 24 3 32 0-2- FAX -3- 28 25 12 2 5 12 0 5 10 15 20 25 30 46 38-4- -5-68 43 21 6 3 1 20 0 10 20 30 40 50 60 70 F F 900 1715 1,402 464 OB NPO 1000 1600 583
24回日本エイズ学会誌1_ indd
10 ICAAP 11 24 9:40 10:10 1 B1F 1. 10 Myung-Hwan Cho 2. Zahid Hussein President of AIDS Society of Asia and the Pacific ASAP 11 24 13:10 15:40 1 B1F 1 13:10 13:55 PS1-1 ART in the Developing World: Progress
資料４：家族形成のための生殖医療（石原委員資料）
資料 4 ICMART (Interna.onal Commi3ee Monitoring ART) IFFS (Interna.onal Federa.on of Fer.lity Socie.es) 30/10/18 2009Infer.lity (clinical defini.on): a disease of the reproduc.ve system defined by the failure
在外教育施設派遣教員安全対策資料 在外教育施設派遣教員安全対策資料
1. 1. 1.1.1. 1.1.2. 1.1.3. 1.1.4. 1.1.5. 1. 2. 1. 3. 1. 4. 1-1 1-2 1-3 2. 1. 2. 2. 2. 3. 2. 4. 2.4.1. 2.4.2. 2-1 2. 5. 2. 6. 2.6.1. 2.6.2. 2.6.3. 2.6.4. 2.6.5. 2. 7. 2.7.1. 2.7.2. 2.7.3. 2.7.4. 2. 8. 2.
untitled
Trademark of American Soybean Association TM http://www.wakachiku.co.jp 8080024 147 TEL 0937611331 1530064 22318 TEL 0334920271 0640807 1136 2 TEL 0115111881 9800014 21028 TEL 0222214325 2600022 322 TEL
1 2 3 4 5 6 7 9 14 10 10 27 11 12 LINE 13 3 14 15 16 17 ADHD 18 IQ 19 20 21 22 23 24 25 26 27 28 29 4 30 31 32 ADHD DVD 1 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 http://www.edu.city.kyoto.jp/seitoshido/
EMS EMS W264
ILCOR-CoSTR 10 Part 10 First Aid (2/5) (introduction) (definition of first aid) (medical emergencies) (injury emergencies) (environmental injuries) 2004 AHA ARC National First Aid Science Advisory Board
DV NPO 1 2 3 3 3 1 1 JICC 5 3 5 1 1 る と き 70 20 5 6 156 6 3 (30 ) 3 2.4 3 5700 90 40 1 1 10 40 10 2 20 10 6 6 25 20 + 5 26 10 6 6 10 3.7 58 30 (30 ) 40 ( ) 16 3 1.1 10 1 1 1 70 ( 8400 ) ( ) 12 15 8
技術流出防止指針公表用.PDF
15 3 1 4 .. 2 2.. 4. 6.10 10.14.16.19.24.26.28 1 2 1 2002 7 3 2002 3 4 2 3 5 4 4 6 7 8 5 5 9 plan (do) (check) (act) 1) 2) 3) 4) 5) 6) 7) 10 11 12 13 14 15 16 17 18 6 6 19 / / 20 21 22 7 23 8 24 25 26
平成20年度内部評価実施結果報告書《本編》
10 11 12 13 14 15 16 17 Plan Do Check Action 1 2 3 4 146 13 20 43 44 45 62 104 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47
untitled
1 1 2 3 2 1 ( 0) 2000 00 3 4 Check Action Do Plan 5 6 14001 5000 5000 1000 1000 7 8 9 10 2004 0.1 0.1 0.0 0.0 0.0 15.3 483.5 0.4 11 12 13 14 http://kankyou.pref.shizuoka.jp/seikan/seikanindex.htm 15 16
-2-
-1- -2- -3- -4- -5- -6- -7- -8- 10-9- -10-1 2 -11-1 1-12- -13- -14- Plan Do Check Action Check Action 1 -15- -16- -17- -18- -19- -20- -21- -22- 10 2 9 3 9 2 1 10 2 9 3 6 4 1 6 6 10 2 10 2 11 1 8 1 8 4
untitled
Quantitative Risk Assessment on the Public Health Impact of Pathogenic Vibrio parahaemolyticus in Raw Oyster 1 15 5 23 48 2 21 1 16 1 16 1 11 3 1 3 4 23 1 2 16 12 16 5 6 Hazard IdentificationExposure
（プロ1特別企画用ショート版） （詳細頁レ）.indd
Professor, Department of Cardiovascular Medicine Graduate School of Medicine and Faculty of Medicine, The University of Tokyo Ryozo Nagai Former Senior Clinical Advisor, Centers for Medicare & Medicaid
01
01 2 1 3 6EFIKL 45EFIKL 8 B 7 DGL J FK M 9H @N A AC C O O O O 02 03 04 05 06 2 1 3 07 1 2 3 4 5 6 7 8 9 10 management 08 09 environment 10 11 environment 12 13 L M N O P Q R S T U V W X Y Z [ \ ] G H I
地域社会の安全犯罪抑止―対策の現状とその課題
154 2002. 2.4 156 2003 2003.12 13 14 14 2004. 9 2002 14 2853739 1996 1948 1599968 1.78 1973 119 0549 2.4 19451949 19481949160 19501954 1950 130 2800 1951 19551964 19951964 30 130 19651973 1965 40 1973
1 2 3 4 5 6 0.4% 58.4% 41.2% 10 65 69 12.0% 9 60 64 13.4% 11 70 12.6% 8 55 59 8.6% 0.1% 1 20 24 3.1% 7 50 54 9.3% 2 25 29 6.0% 3 30 34 7.6% 6 45 49 9.7% 4 35 39 8.5% 5 40 44 9.1% 11 70 11.2% 10 65 69 11.0%
_<74B0><5883><611F><67D3><30DD><30B1><30D7><30ED>_<5FF5><6821>2.pdf
33 The 33rd Annual Meeting of Japanese Society for Infection Prevention and Control The 33rd Annual Meeting of Japanese Society for Infection Prevention and Control The 33rd Annual Meeting of Japanese
研究レポート表紙.PDF
No.118 November 2001 ISO ISO takeishi@fri.fujitsu.co.jp ISO14001 CEAR A4823 1. ISO14000 ISO14000 ISO14001 2. ISO ISO. ISO14001 ISO9000 OHSAS18001 18002 ISO14001 ISO IEC13335 ISO10006. ISO ISO14001 ISO9000
NPO 1 2 3 77 4 5 6 7 21 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67
20110124-02-01
100 13 13 148 4 60 8 21 18 3 2 19 2 23 3 22 22 9 23 10 1 2 18 3 3 60.0 31.12 33.3 24.5 23.1 22.7 29 201714 22 13.310 32 12.137 11.2 65 22 20.532 27.437 28.7 18 1 46.31 81.6 20.9 23.821.4 19.0 34.9 28.9
勘定科目別経理セミナー
16 8 21 2 15-1 (1) (2) (3) (4) (5) 3 (6) (7) (1) (2) (3) (1) (2) (3) 4 (4) (1) (2) (3) 5 8/1 8/30 9/20 20 (1) (2) (3) (4) 6 (1) (2) (3) (4) 7 (1) (2) (3) (4) (5) (6) 8 (1) (2) 50% (1) (2) 9 (3) (1) (2)
untitled
420 40 41 100 18 6 18 61 17 1 20 29 10 12 2.0 17 4.3 12 17 400-10 65 40,438 17 24.2 19.9 15 35 60 17 60 17 1700 17 65 2 17 23 58,000 28 58,900 1 23 2.77 / 28 2.63 / 7 17 15 15 11,769 3 60 17 45,618 59.36
- 82 -
- 82 - 1 2 3 4 5 6-83 - 7 3,000 100 8 9 10 11 4559 59 24 51 61 51-84 - 5373-85 - 3,000 100 3,000 12 100-86 - 1,000 44 5462-87 - 3,000 23 24 10,000 23 8,000 24 2,000 22 2,000 23 22 2,000 8,000 3,000 22
Microsoft Word - 文書4
5 8 NPO http://plaza.rakuten.co.jp/dassen/ http://www.youtube.com/watch?v=rcdkhqunyte 20 10 10 10 20 10 20 10 20 20 2 1 '93.5 http://youtu.be/gwrfcglitxk 7 1 13 5000 20 1000 60 550 30 20 1 9 14 3 5 50
大崎市耐震改修促進計画（案）
1 1 2 2 4 2520 5661 3 1 4 2 12 11 15 11 12 20 1 11 5 3 19781933 6 7 4 8 9 1 10 7 11 50 90 3 12 56 1 13 14 15 2 56,041 30,528 54,572 10,991 27 27 27 16 17 18 19 1 20 21 22 2 3 4 23 5 24 6 25 1-26 2 3 4
1 2 (1) (2) (3) 10 (4) 10 (5) 12 3 (1) 13 (2) 13 (3) 14 4 (1) 14 (2) 15 (3) 15 (4) 16 (5) 16 1 2009 24 1,440 360 2 (1) 1,800 (2) 23 4 1 102 169 73 96 13 5 1 178 69 1 NPO 4 1 2 40 35 4 3 23 4 1 1 443 622-0844
01_表紙_修
0% 20% 40% 60% 80% 100% H7 H12 H17 H22 19.1% 17.1% 15.5% 14.4% 65.1% 64.5% 63.9% 62.2% 15.8% 18.4% 20.6% 23.4% H27 H27 H27 13.7% 13.0% 12.6% 59.2% 57.4% 60.7% 27.1% 29.6% 26.6% 15 1564 65 3.50 3.00 2.50
untitled
2006 Progress Report on the Economic Well-Being of Working-Age People with Disabilities Employment of Disabled People in Europe in 2002 Statistics in Focus Code of Practice on Managing Disability in the
untitled
5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg
Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo
Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly
”Y‰Æ”ЛïŸ_‘W40−ª3/ ‰{fic
Assisted Reproductive Technology ART ART In Vitro Fertilization- Embryo Transfer IVF-ET,ART, ART ART ART IVF-ET IVF-ET IVF-ET IVF-ET IVF-ET ART ART ART IVF- ET, ART ART IVF-ET ART Ovarian Hyper Stimulation
1.... 1 1.1...1 1.2...2 2.... 3 2.1...3 2.2...3 2.3...4 2.4...5 3.... 6 3.1...6 3.2...19 3.3...20 4.... 22 4.1...22 4.2...23 4.3...23 4.4...24 4.5...34 4.6...34 4.7 PDCA...35 1. 1.1 2 261 46 26 JR 17 1
2007 12 12 2006 1722,709 99,546 59,419 0.32 2.75 1.65 37 11 2.1 3.4 13 2006 13 17 2006 1987 2007 200617 2006 21 281-286 2009 30 150-157 -------------------------------------------------------------- 2007
八戸大学紀要_45_表1pdf
1 2 189 43 35 19 7 2 2000 60 2007 Key words : ICD - 10 I. 1. 1 1 2 2 4 4 1 2 2. 105 45 II. 1. 2011 MMA Mixed Martial Arts : 2. 1 1 189 2 ICD - 10 2.0 3 2000 2007 CDC Centers for Disease Control and Preven-
18 (1) US (2) US US US 90 (3) 2 8 1 18 108 2 2,000 3 6,000 4 33 2 17 5 2 3 1 2 8 6 7 7 2 2,000 8 1 8 19 9 10 2 2 7 11 2 12 28 1 2 11 7 1 1 1 1 1 1 3 2 3 33 2 1 3 2 3 2 16 2 8 3 28 8 3 5 13 1 14 15 1 2
自殺防止のために国が実施できる政策について
10 1998 8,2611,755 32 1899 82 18 646 701 1722 13 1880 1933 10 1998 13 2001 14 2002 12 2003. 17 10 suisidology 11 12 13 14 18 2003. 15 WHO WHO, WHO Statistical Information System (WHOSIS) 16 WHO, Suicide
磐田市水道事業ビジョン
20162025 I w a t a C i t y W a t e r w o r k s V i s i o n C o n t e n t s 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2049 (H21) (H22) (H23) (H24) (H25) (H26)
橡00論点公開表紙2000.PDF
1 2 3 4 Information Technology 5 6 7 CS 5332 ( 9 ), 1000 1 2 3 1 2 3 1 2 (b) Polluter Pays PrinciplePPP WHO Dual System Deutschland Grnerpunkt ,,, Management
-1-15 12 14 13 13 76. 22.7 9.8 2.3 13 0.1 1.6 21.1 43.5 32.6 0.1 9.7 47.6 36.7 15 10 32 12 21 13 12-2- -3-10 12 57 60 12 11 12 13 10 14 10 20 -4-13 36.6 15 12 13, 102 277 150 . 3033 31 58 38 56 45 60 31
精神障害者ホームヘルプサービスにおける教育の充実化
1987 62 1993 1999 11 2002 14 1999 11 2002 14 12 7 2 1 disease impairment disability handicap WHO 1980 1999 11 1,530 4,020 2002 14 1995 1998 2 10 2000 12 2003 15 1991 1994 51 1997 1998 10 3,261 ⑴ 3 p.82
. 1 EBM Evidence-Based Medicine JCAHO 2
1 1 . 1 EBM Evidence-Based Medicine JCAHO 2 . 2 3 . 4 . 5 . When Where Who What Why How 6 . 7 3 DPC . 20 30 8 20 30 . (1) 9 3 BP mm mm . (2) 10 . http://epath.medis.or.jp/ 11 . 12 . 13 . 14 15 . PDCA Plan
社会学部紀要 ３号／５．新野
2009 3 1 3 101 136 ACommunity of Principles : Christian Social Work Education and Diversional Therapy Education Miyoko SHINNO 2007 12 DT 3 1 2 1997 3 2004 Diversional Therapy DT DT DT 1 1 1997 2 A 175
最終答申Ｐ.PDF
1 2 3 4 5 6 7 8 9 10 (1) (2) (3) (4) 11 12 15 13 14 1 1 1 1 1 10 11 12 13 14 ( ) 105 H 15 16 17 18 1 19 15 20 1 15 17 13 15 21 1 1 15 22 23 ha ha 24 25 20019 3 26 a a 27 NATO ace Realignment Closure 28
untitled
186 17 100160250 1 10.1 55 2 18.5 6.9 100 38 17 3.2 17 8.4 45 3.9 53 1.6 22 7.3 100 2.3 31 3.4 47 OR OR 3 1.20.76 63.4 2.16 4 38,937101,118 17 17 17 5 1,765 1,424 854 794 108 839 628 173 389 339 57 6 18613
